MedTrace Logo

Supplements SMOF in TPN for Liver Transplantation Recipients

NCT04572373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2020-10-08

No results posted yet for this study

Summary

Liver transplantation (LT) is one of the widely recognised and leading treatments for end-stage liver disease. Nutrition impacts its success. Total parenteral nutrition (TPN) is usually prescribed for patients recommended prolonged fasting after LT. The supplement of SMOFlipid (soybean oil, MCT oil, olive oil, and fish oil) is easily metabolised to produce energy, and it possesses anti-inflammatory effects; however, SMOFlipid emulsion use raises concerns regarding coagulopathy after LT. This study investigated the postoperative correlation between SMOFlipid and coagulation in LT.

Conditions

  • Liver Transplantation
  • Total Parenteral Nutrition
  • End-stage Liver Disease

Interventions

DIETARY_SUPPLEMENT

SMOFlipid

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Chih-Che Lin, MD · Department of Surgery, Kaohsiung Chang Gung Memorial Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04572373 on ClinicalTrials.gov